Evaluation and Prediction of the Effect of EECP on HR-NICE Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT05718622
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Registry
-
NCT05718622
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT05718622. Randomized; triple masking; primary purpose treatment. Start 2022-11-10 (actual); primary completion 2026-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation and Prediction of the Effect of EECP on HR-NICE Patients
- Condition
- Stroke, Ischemic
- Intervention (Device)
- real EECP
- Intervention (Device)
- sham EECP
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
Record details
- Record id
cardio:ct-nct05718622- Content hash
4875889a2646fc51302434223f1a08bb1369a2c3c9dc43e49804dcd0f8378842